\-\ Texto\\:\\ \ \(0\)\
\-\ vitals\\:\\ t\\ 97\\.6\\ hr\\ 64\\ bp\\ 167\\/71\\ rr\\ 16\\ sat\\ 100\\%\\ on\\ ra\ \(0\)\
\-\ gen\\:\\ well\\-nourished\\,\\ pale\\,\\ somnolent\ \(0\)\
\-\ heent\\:\\ \\ eomi\\ peerla\\,\\ no\\ focal\\ abnormalities\ \(0\)\
\-\ lungs\\:\\ cta\\ b\\,\\ no\\ wheeze\\,\\ rales\\,\\ ronchi\ \(0\)\
\-\ heart\\:\\ rrr\\ nl\\ s1\\ and\\ s2\\,\\ no\\ m\\/r\\/g\ \(0\)\
\-\ neuro\\:cn\\ ii\\-xii\\ intact\\.\\ \\ motor\\ grossly\\ intact\\.\\ \\ sensation\\ grossly\\ intact\ \(0\)\
\-\ laboratory\\:\ \(3\)\
\-\ cbc\\ \ \(0\)\
\-\ wbc\\ 10\\.6\\*\\ hgb12\\.8\\ hct\\ 36\\.3\\ plt\\ 313\\ mcv\\ 88\\ rdw\\ 12\\.3\\ diff\\:96\\%\\*neutrophils\\,\\ 4\\%\\ lymphocytes\\ 0\\%\\ mono\\ 0\\%\\ eos\\ 0\\%basos\ \(0\)\
\-\ bmp\\ \ \(0\)\
\-\ na\\ 131\\*\\ k\\ 3\\.7\\ cl\\ 93\\ hco3\\ 26\\ \\ bun\\ 9\\ creat\\ 0\\.66\\ gluc\\ 154\\*\ \(0\)\
\-\ ca\\ 9\\.4\\ anion\\ gap\\ 12\ \(0\)\
\-\ lfts\\:\ \(0\)\
\-\ tot\\.\\ prot\\ 6\\.7\\ alb\\ 3\\.2\\ t\\.bili\\ 1\\.3\\ \\ ast\\ 25\\ alt\\ 17\\ alk\\ phos\\ 97\ \(0\)\
\-\ coags\ \(1\)\
\-\ pt\\ 10\\.9\\ aptt\\ 29\\.0\\ inr\\ 1\\.1\ \(0\)\
\-\ esr\\ 83\\*\\ crp\\ 1\\.5\\*\ \(0\)\
\-\ ua\\ ph\\ 7\\.5\\*\\ glucose\\ 70\\*\\ ketone\\ 40\\*\\ 6\\ rbcs\\ trace\\ bacteria\\,\\ trace\\ crystals\ \(0\)\
\-\ ucx\\:\\ \\>100\\,000\\ cfu\\ of\\ alpha\\ hemolytic\\ strep\\ vs\\.\\ gm\\+\\ staph\ \(0\)\
\-\ hiv\\ negative\ \(0\)\
\-\ the\\ patient\\ was\\ seen\\ by\\ neurosurgery\\ on\\ admission\\,\\ the\\ initial\\ impression\\ was\\ right\\ temporal\\ abscess\\.\\ \\ there\\ did\\ not\\ appear\\ to\\ be\\ an\\ extra\\-cranial\\ source\\ of\\ infection\\ \\(tte\\ and\\ ct\\ scan\\ of\\ chest\\ were\\ both\\ unremarkable\\)\\ \\ \\ the\\ patient\\ was\\ placed\\ on\\ high\\-dose\\ steroids\\,\\ antibiotics\\ and\\,\\ anti\\-emetics\\ \\ then\\ scheduled\\ for\\ right\\ temporal\\ craniotomy\\ to\\ drain\\ the\\ abscess\\.\\ \\ the\\ patient\\ tolerated\\ the\\ surgery\\ well\\ with\\ no\\ residual\\ neurological\\ deficits\\ and\\ resolution\\ of\\ nausea\\ and\\ vomiting\\.\\ \\ she\\ was\\ discharged\\ home\\ 2\\ days\\ post\\-surgery\\ on\\ linezolid\\ with\\ follow\\-up\\ in\\ neurosurgery\\ clinic\\.\\ \\ \ \(0\)\
\-\ the\\ neurosurgery\\ operative\\ report\\ confirms\\ the\\ presence\\ of\\ an\\ abscess\\.\\ \\ a\\ gram\\ stain\\ of\\ fluid\\ recovered\\ from\\ the\\ abscess\\ showed\\ numerous\\ gm\\+\\ cocci\\ in\\ clusters\\.\\ \\ culture\\ of\\ this\\ abscess\\ fluid\\ grew\\ methicillin\\ resistant\\ staph\\ aureus\\ \\(resist\\:\\ amp\\,\\ erythro\\,\\ oxacillin\\,\\ penicillin\\.\\ \\ sens\\:\\ dapto\\,\\ levoflox\\,\\ linezolid\\,\\ tet\\,\\ tmp\\/smx\\,\\ vanc\\,\\ gent\\,\\ clinda\\)\\ \\.\\ \\ cultures\\ for\\ anerobes\\,\\ mycosis\\ or\\ tuberculosis\\ were\\ all\\ negative\\.\ \(0\)\
\-\ a\\ ct\\ performed\\ at\\ the\\ time\\ of\\ presentation\\ showed\\ a\\ 2\\.8\\ cm\\ ring\\-enhancing\\ right\\ temporal\\ lesion\\ with\\ surrounding\\ vasogenic\\ edema\\.\\ \\ \\(images\\ not\\ available\\ for\\ review\\)\ \(0\)\
\-\ there\\ is\\ an\\ approximately\\ 2\\.6\\ x\\ 2\\.7\\ cm\\ ring\\-enhancing\\ lesion\\ within\\ the\\ lateral\\ aspect\\ of\\ the\\ right\\ temporal\\ lobe\\.\\ this\\ lesion\\ has\\ a\\ uniform\\,\\ smooth\\ rim\\ of\\ enhancement\\ with\\ decreased\\ t2\\ signal\\ characteristics\\,\\ and\\ central\\ areas\\ of\\ restricted\\ diffusion\\.\\ \\ there\\ is\\ vasogenic\\ edema\\ surrounding\\ the\\ lesion\\ throughout\\ the\\ right\\ temporal\\ lobe\\ which\\ tracks\\ into\\ the\\ basal\\ ganglia\\.\\ \\ \ \(0\)\
\-\ there\\ is\\ \\ mass\\ effect\\ with\\ sulcal\\ effacement\\,\\ compression\\ of\\ the\\ right\\ lateral\\ ventricle\\,\\ and\\ 7\\ mm\\ of\\ midline\\ shift\\ at\\ the\\ septum\\ pellucidum\\.\\ there\\ is\\ no\\ hydrocephalus\\.\\ \ \(0\)\
\-\ no\\ additional\\ regions\\ of\\ pathologic\\ enhancement\\ or\\ areas\\ concerning\\ for\\ abscess\\ are\\ identified\\.\\ there\\ is\\ no\\ area\\ of\\ acute\\ infarction\\.\\ flow\\-related\\ signal\\ within\\ the\\ major\\ intracranial\\ vessels\\ is\\ preserved\\.\\ \\ incidental\\ note\\ is\\ made\\ of\\ thickening\\ of\\ the\\ outer\\ table\\ of\\ the\\ calvarium\\ in\\ the\\ bifrontal\\ convexity\\,\\ of\\ doubtful\\ clinical\\ significance\\,\\ likely\\ representing\\ an\\ old\\ cephalohematoma\\.\ \(0\)\
\-\ pyogenic\\ abscess\\ \\(mrsa\\)\ \(0\)\
\-\ \\â\\€\\¢\\ brain\\ metastasis\\ w\\/\\ occult\\ primary\ \(0\)\
\-\ lung\\,\\ breast\\,\\ skin\\,\\ kidney\\,\\ gi\\ tract\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ primary\\ brain\\ tumor\\ \\(gbm\\,\\ lymphoma\\)\ \(0\)\
\-\ \\â\\€\\¢\\ pyogenic\\ abscess\ \(0\)\
\-\ \\â\\€\\¢\\ infarct\\/hemorrhage\ \(0\)\
\-\ \\â\\€\\¢\\ subdural\\ hematoma\ \(3\)\
\-\ \\â\\€\\¢\\ multiple\\ sclerosis\ \(0\)\
\-\ 50\\ y\\.o\\.\\ woman\\ with\\ a\\ chief\\ complaint\\ of\\ persistent\\ nausea\\ and\\ vomiting\\ of\\ 3\\ weeks\\ duration\\.\\ \\ the\\ patient\\ denied\\ fever\\,\\ chills\\,\\ trauma\\,\\ or\\ prior\\ intracranial\\ problems\\.\ \(0\)\
\-\ the\\ patient\\ is\\ a\\ 50\\ year\\-old\\ woman\\ with\\ an\\ intraparenchymal\\ mass\\ confirmed\\ by\\ both\\ ct\\ and\\ mr\\ imaging\\.\\ \\ this\\ mass\\ measures\\ approximately\\ 3\\ cm\\ in\\ diameter\\ and\\ demonstrates\\ ring\\-enhancement\\ on\\ both\\ ct\\ and\\ mr\\.\\ \\ the\\ patient\\ is\\ hiv\\ negative\\ and\\ has\\ no\\ findings\\ in\\ her\\ labs\\ or\\ on\\ physical\\ exam\\ concerning\\ for\\ immunodeficiency\\.\\ \\ the\\ mass\\ is\\ likely\\ responsible\\ for\\ the\\ patient\\'s\\ nausea\\ and\\ vomiting\\ as\\ well\\ as\\ for\\ her\\ metabolic\\ derangements\\.\\ \\ as\\ such\\,\\ some\\ treatment\\ should\\ be\\ instituted\\ to\\ relieve\\ the\\ patient\\'s\\ symptoms\\.\\ \\ \ \(0\)\
\-\ the\\ major\\ drive\\ in\\ this\\ case\\,\\ then\\,\\ was\\ the\\ characterization\\ of\\ the\\ patient\\'s\\ intraparenchymal\\ mass\\ in\\ order\\ determine\\ the\\ course\\ that\\ this\\ treatment\\ should\\ take\\.\\ \\ the\\ differential\\ of\\ intraparenchymal\\ subcortical\\ ring\\-enhancing\\ lesions\\ is\\ extensive\\ and\\ includes\\ tumor\\ \\(both\\ primary\\ and\\ metastatic\\)\\,\\ pyogenic\\ abscess\\,\\ infarct\\ or\\ hemorrhage\\,\\ and\\ demyelinating\\ disease\\,\\ such\\ as\\ multiple\\ sclerosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\*\\:\\ 0\\.05594206368729505\ \(0\)\
\-\ abscess\\:\\ 0\\.03178630875452079\ \(0\)\
\-\ ring\\-enhancing\\:\\ 0\\.024825928526190186\ \(0\)\
\-\ gm\\+\\:\\ 0\\.023047106990762085\ \(0\)\
\-\ linezolid\\:\\ 0\\.023047106990762085\ \(0\)\
\-\ temporal\\:\\ 0\\.022365299853687168\ \(0\)\
\-\ intraparenchymal\\:\\ 0\\.022274604737401366\ \(0\)\
\-\ pyogenic\\:\\ 0\\.021793811317431435\ \(0\)\
\-\ 0\\:\\ 0\\.02010446654844142\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.018855628387192264\ \(0\)\
\-\ staph\\:\\ 0\\.01677809974161602\ \(0\)\
\-\ \\:\\:\\ 0\\.016252317615552046\ \(0\)\
\-\ \\%\\:\\ 0\\.015633890457615745\ \(0\)\
\-\ \\,\\:\\ 0\\.015570252134327639\ \(0\)\
\-\ trace\\:\\ 0\\.014738469525800135\ \(0\)\
\-\ nausea\\:\\ 0\\.013491137318754247\ \(0\)\
\-\ vomiting\\:\\ 0\\.012794348388411297\ \(0\)\
\-\ hiv\\:\\ 0\\.012386878379243864\ \(0\)\
\-\ intact\\:\\ 0\\.01230888086940477\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.012290308639967747\ \(0\)\
\-\ vasogenic\\:\\ 0\\.012093761259974044\ \(0\)\
\-\ grossly\\:\\ 0\\.011724928323346841\ \(0\)\
\-\ concerning\\:\\ 0\\.011724928323346841\ \(0\)\
\-\ 167\\/71\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ hgb12\\.8\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ diff\\:96\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ basos\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ 0\\.66\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ ketone\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ ucx\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ cfu\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ anti\\-emetics\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ erythro\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ oxacillin\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ sens\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ dapto\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ levoflox\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ tet\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ tmp\\/smx\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ vanc\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ gent\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ clinda\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ infarct\\/hemorrhage\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ ring\\-enhancement\\:\\ 0\\.011523553495381042\ \(0\)\
\-\ both\\:\\ 0\\.011410196029731352\ \(0\)\
\-\ 313\\:\\ 0\\.01061747874955105\ \(0\)\
\-\ t\\.bili\\:\\ 0\\.01061747874955105\ \(0\)\
\-\ 29\\.0\\:\\ 0\\.01061747874955105\ \(0\)\
\-\ methicillin\\:\\ 0\\.01061747874955105\ \(0\)\
\-\ resist\\:\\ 0\\.01061747874955105\ \(0\)\
\-\ amp\\:\\ 0\\.01061747874955105\ \(0\)\
\-\ anerobes\\:\\ 0\\.01061747874955105\ \(0\)\
\-\ doubtful\\:\\ 0\\.01061747874955105\ \(0\)\
\-\ derangements\\:\\ 0\\.01061747874955105\ \(0\)\
\-\ drive\\:\\ 0\\.01061747874955105\ \(0\)\
\-\ major\\:\\ 0\\.010445063681990748\ \(0\)\
\-\ 36\\.3\\:\\ 0\\.010087459000390049\ \(0\)\
\-\ 154\\:\\ 0\\.010087459000390049\ \(0\)\
\-\ tot\\:\\ 0\\.010087459000390049\ \(0\)\
\-\ flow\\-related\\:\\ 0\\.010087459000390049\ \(0\)\
\-\ patient\\:\\ 0\\.010077552128428093\ \(0\)\
\-\ negative\\:\\ 0\\.01000831435833284\ \(0\)\
\-\ there\\:\\ 0\\.00997423965854893\ \(0\)\
\-\ primary\\:\\ 0\\.009926997109394887\ \(0\)\
\-\ 97\\.6\\:\\ 0\\.009711404003721055\ \(0\)\
\-\ somnolent\\:\\ 0\\.009711404003721055\ \(0\)\
\-\ peerla\\:\\ 0\\.009711404003721055\ \(0\)\
\-\ 12\\.3\\:\\ 0\\.009711404003721055\ \(0\)\
\-\ penicillin\\:\\ 0\\.009711404003721055\ \(0\)\
\-\ mycosis\\:\\ 0\\.009711404003721055\ \(0\)\
\-\ immunodeficiency\\:\\ 0\\.009711404003721055\ \(0\)\
\-\ intracranial\\:\\ 0\\.009441860750038437\ \(0\)\
\-\ coags\\:\\ 0\\.009419713086970455\ \(0\)\
\-\ aptt\\:\\ 0\\.009419713086970455\ \(0\)\
\-\ extra\\-cranial\\:\\ 0\\.009419713086970455\ \(0\)\
\-\ gluc\\:\\ 0\\.009181384254560056\ \(0\)\
\-\ 6\\.7\\:\\ 0\\.009181384254560056\ \(0\)\
\-\ 10\\.9\\:\\ 0\\.009181384254560056\ \(0\)\
\-\ lesion\\:\\ 0\\.009100942358172312\ \(0\)\
\-\ no\\:\\ 0\\.008998108765529955\ \(0\)\
\-\ cm\\:\\ 0\\.008988063207125434\ \(0\)\
\-\ 9\\.4\\:\\ 0\\.008979880097923117\ \(0\)\
\-\ anion\\:\\ 0\\.008979880097923117\ \(0\)\
\-\ prot\\:\\ 0\\.008979880097923117\ \(0\)\
\-\ high\\-dose\\:\\ 0\\.008979880097923117\ \(0\)\
\-\ eos\\:\\ 0\\.008805329257891062\ \(0\)\
\-\ hco3\\:\\ 0\\.008805329257891062\ \(0\)\
\-\ tte\\:\\ 0\\.008805329257891062\ \(0\)\
\-\ post\\-surgery\\:\\ 0\\.008805329257891062\ \(0\)\
\-\ tracks\\:\\ 0\\.008805329257891062\ \(0\)\
\-\ creat\\:\\ 0\\.008651364505399056\ \(0\)\
\-\ wheeze\\:\\ 0\\.00851363834114046\ \(0\)\
\-\ mono\\:\\ 0\\.00851363834114046\ \(0\)\
\-\ 7\\.5\\:\\ 0\\.00851363834114046\ \(0\)\
\-\ 100\\,000\\:\\ 0\\.00851363834114046\ \(0\)\
\-\ clusters\\:\\ 0\\.00851363834114046\ \(0\)\
\-\ 50\\:\\ 0\\.008499341219983803\ \(0\)\
\-\ bifrontal\\:\\ 0\\.00838904987080801\ \(0\)\
\-\ instituted\\:\\ 0\\.00838904987080801\ \(0\)\
\-\ alb\\:\\ 0\\.008275309508730061\ \(0\)\
\-\ hemolytic\\:\\ 0\\.008275309508730061\ \(0\)\
\-\ cocci\\:\\ 0\\.008275309508730061\ \(0\)\
\-\ well\\-nourished\\:\\ 0\\.008170678518307137\ \(0\)\
\-\ ronchi\\:\\ 0\\.008170678518307137\ \(0\)\
\-\ 10\\.6\\:\\ 0\\.008170678518307137\ \(0\)\
\-\ rdw\\:\\ 0\\.008170678518307137\ \(0\)\
\-\ 131\\:\\ 0\\.008170678518307137\ \(0\)\
\-\ sulcal\\:\\ 0\\.008170678518307137\ \(0\)\
\-\ characterization\\:\\ 0\\.008170678518307137\ \(0\)\
\-\ is\\:\\ 0\\.008085226878734617\ \(0\)\
\-\ crystals\\:\\ 0\\.008073805352093124\ \(0\)\
\-\ strep\\:\\ 0\\.008073805352093124\ \(0\)\
\-\ cephalohematoma\\:\\ 0\\.008073805352093124\ \(0\)\
\-\ sclerosis\\:\\ 0\\.008024353551441423\ \(0\)\
\-\ 93\\:\\ 0\\.00798361859197946\ \(0\)\
\-\ rbcs\\:\\ 0\\.00798361859197946\ \(0\)\
\-\ then\\:\\ 0\\.00795024020502507\ \(0\)\
\-\ 3\\.7\\:\\ 0\\.007899254512061067\ \(0\)\
\-\ gap\\:\\ 0\\.007899254512061067\ \(0\)\
\-\ mrsa\\:\\ 0\\.007899254512061067\ \(0\)\
\-\ m\\/r\\/g\\:\\ 0\\.007820006640405597\ \(0\)\
\-\ 97\\:\\ 0\\.007820006640405597\ \(0\)\
\-\ mass\\:\\ 0\\.007767718999657285\ \(0\)\
\-\ 3\\.2\\:\\ 0\\.007745289759569063\ \(0\)\
\-\ an\\:\\ 0\\.0077232997665668615\ \(0\)\
\-\ 2\\.8\\:\\ 0\\.007607563595310466\ \(0\)\
\-\ mcv\\:\\ 0\\.007543785602932123\ \(0\)\
\-\ cl\\:\\ 0\\.007543785602932123\ \(0\)\
\-\ resistant\\:\\ 0\\.007543785602932123\ \(0\)\
\-\ calvarium\\:\\ 0\\.007543785602932123\ \(0\)\
\-\ areas\\:\\ 0\\.007517247506525665\ \(0\)\
\-\ neutrophils\\:\\ 0\\.007482975124978015\ \(0\)\
\-\ alpha\\:\\ 0\\.007482975124978015\ \(0\)\
\-\ pale\\:\\ 0\\.007424868245800455\ \(0\)\
\-\ 2\\.7\\:\\ 0\\.007424868245800455\ \(0\)\
\-\ \\'s\\:\\ 0\\.007388418111243314\ \(0\)\
\-\ bmp\\:\\ 0\\.0073692347629000675\ \(0\)\
\-\ lfts\\:\\ 0\\.0073692347629000675\ \(0\)\
\-\ aureus\\:\\ 0\\.0073692347629000675\ \(0\)\
\-\ 2\\.6\\:\\ 0\\.0073692347629000675\ \(0\)\
\-\ surrounding\\:\\ 0\\.007344222913371935\ \(0\)\
\-\ showed\\:\\ 0\\.007324975863852801\ \(0\)\
\-\ 88\\:\\ 0\\.007315872678559866\ \(0\)\
\-\ ph\\:\\ 0\\.007315872678559866\ \(0\)\
\-\ ii\\-xii\\:\\ 0\\.0072646037724771444\ \(0\)\
\-\ responsible\\:\\ 0\\.0072646037724771444\ \(0\)\
\-\ lymphocytes\\:\\ 0\\.0072152700104080635\ \(0\)\
\-\ 1\\.3\\:\\ 0\\.0072152700104080635\ \(0\)\
\-\ grew\\:\\ 0\\.0072152700104080635\ \(0\)\
\-\ should\\:\\ 0\\.007122113835003398\ \(0\)\
\-\ plt\\:\\ 0\\.007121859599973887\ \(0\)\
\-\ significance\\:\\ 0\\.007121859599973887\ \(0\)\
\-\ mr\\:\\ 0\\.007098560710971069\ \(0\)\
\-\ bacteria\\:\\ 0\\.007077543846149467\ \(0\)\
\-\ pellucidum\\:\\ 0\\.007077543846149467\ \(0\)\
\-\ right\\:\\ 0\\.007071621247924836\ \(0\)\
\-\ tolerated\\:\\ 0\\.007034681332655362\ \(0\)\
\-\ nl\\:\\ 0\\.006993179766231073\ \(0\)\
\-\ inr\\:\\ 0\\.006993179766231073\ \(0\)\
\-\ such\\:\\ 0\\.006983876574747326\ \(0\)\
\-\ 1\\.1\\:\\ 0\\.006952955375817016\ \(0\)\
\-\ gram\\:\\ 0\\.006913931894575603\ \(0\)\
\-\ recovered\\:\\ 0\\.006913931894575603\ \(0\)\
\-\ convexity\\:\\ 0\\.006913931894575603\ \(0\)\
\-\ relieve\\:\\ 0\\.006913931894575603\ \(0\)\
\-\ demyelinating\\:\\ 0\\.006913931894575603\ \(0\)\
\-\ approximately\\:\\ 0\\.006911942030210674\ \(0\)\
\-\ eomi\\:\\ 0\\.006876039689512528\ \(0\)\
\-\ stain\\:\\ 0\\.006876039689512528\ \(0\)\
\-\ crp\\:\\ 0\\.006839215013739069\ \(0\)\
\-\ 83\\:\\ 0\\.006803399361205586\ \(0\)\
\-\ subcortical\\:\\ 0\\.006803399361205586\ \(0\)\
\-\ as\\:\\ 0\\.006758575194217661\ \(0\)\
\-\ occult\\:\\ 0\\.006734584023316146\ \(0\)\
\-\ brain\\:\\ 0\\.006722487642621599\ \(0\)\
\-\ her\\:\\ 0\\.00671741610061421\ \(0\)\
\-\ craniotomy\\:\\ 0\\.006701488849480472\ \(0\)\
\-\ for\\:\\ 0\\.006671577830717655\ \(0\)\
\-\ preserved\\:\\ 0\\.006606952036958085\ \(0\)\
\-\ table\\:\\ 0\\.006606952036958085\ \(0\)\
\-\ gbm\\:\\ 0\\.006606952036958085\ \(0\)\
\-\ chief\\:\\ 0\\.006606952036958085\ \(0\)\
\-\ uniform\\:\\ 0\\.006547524096988468\ \(0\)\
\-\ or\\:\\ 0\\.006545900320024232\ \(0\)\
\-\ \\)\\:\\ 0\\.006529103065089067\ \(0\)\
\-\ alk\\:\\ 0\\.006518793499970461\ \(0\)\
\-\ phos\\:\\ 0\\.006518793499970461\ \(0\)\
\-\ was\\:\\ 0\\.006459330210546973\ \(0\)\
\-\ take\\:\\ 0\\.006409797932729872\ \(0\)\
\-\ sat\\:\\ 0\\.0063585290266471505\ \(0\)\
\-\ fluid\\:\\ 0\\.006349383280010073\ \(0\)\
\-\ edema\\:\\ 0\\.006318754220735401\ \(0\)\
\-\ likely\\:\\ 0\\.006301411675648775\ \(0\)\
\-\ this\\:\\ 0\\.006281942570680608\ \(0\)\
\-\ ct\\:\\ 0\\.0062499537432263675\ \(0\)\
\-\ bun\\:\\ 0\\.006171469100319474\ \(0\)\
\-\ gen\\:\\ 0\\.006149862169664296\ \(0\)\
\-\ rales\\:\\ 0\\.006149862169664296\ \(0\)\
\-\ s2\\:\\ 0\\.006149862169664296\ \(0\)\
\-\ drain\\:\\ 0\\.006149862169664296\ \(0\)\
\-\ effacement\\:\\ 0\\.006128606586825368\ \(0\)\
\-\ ra\\:\\ 0\\.006107691107941131\ \(0\)\
\-\ 64\\:\\ 0\\.006087105020401079\ \(0\)\
\-\ k\\:\\ 0\\.006087105020401079\ \(0\)\
\-\ hct\\:\\ 0\\.006066838109896549\ \(0\)\
\-\ ast\\:\\ 0\\.006066838109896549\ \(0\)\
\-\ alt\\:\\ 0\\.006066838109896549\ \(0\)\
\-\ subdural\\:\\ 0\\.006046880629987022\ \(0\)\
\-\ na\\:\\ 0\\.006027223273954944\ \(0\)\
\-\ operative\\:\\ 0\\.006027223273954944\ \(0\)\
\-\ lobe\\:\\ 0\\.006011308099146494\ \(0\)\
\-\ cn\\:\\ 0\\.006007857148745609\ \(0\)\
\-\ enhancement\\:\\ 0\\.005988205924504669\ \(0\)\
\-\ glucose\\:\\ 0\\.005969964943682534\ \(0\)\
\-\ impression\\:\\ 0\\.005969964943682534\ \(0\)\
\-\ culture\\:\\ 0\\.0059514229371571015\ \(0\)\
\-\ ua\\:\\ 0\\.005933140267909075\ \(0\)\
\-\ confirms\\:\\ 0\\.005933140267909075\ \(0\)\
\-\ outer\\:\\ 0\\.005933140267909075\ \(0\)\
\-\ duration\\:\\ 0\\.005915109781461578\ \(0\)\
\-\ source\\:\\ 0\\.005897324615375592\ \(0\)\
\-\ signal\\:\\ 0\\.005890390405941905\ \(0\)\
\-\ cta\\:\\ 0\\.005828509277486152\ \(0\)\
\-\ w\\/\\:\\ 0\\.005795414103650478\ \(0\)\
\-\ the\\:\\ 0\\.005782976615053627\ \(0\)\
\-\ s1\\:\\ 0\\.005763136178695744\ \(0\)\
\-\ neuro\\:\\ 0\\.005763136178695744\ \(0\)\
\-\ representing\\:\\ 0\\.005763136178695744\ \(0\)\
\-\ cultures\\:\\ 0\\.0057472912629671895\ \(0\)\
\-\ ganglia\\:\\ 0\\.005716166231995008\ \(0\)\
\-\ septum\\:\\ 0\\.005716166231995008\ \(0\)\
\-\ rr\\:\\ 0\\.005700877291128091\ \(0\)\
\-\ rrr\\:\\ 0\\.005700877291128091\ \(0\)\
\-\ on\\:\\ 0\\.005677576567571985\ \(0\)\
\-\ \\(\\:\\ 0\\.005665582166618514\ \(0\)\
\-\ esr\\:\\ 0\\.005656054972855371\ \(0\)\
\-\ determine\\:\\ 0\\.005656054972855371\ \(0\)\
\-\ 100\\:\\ 0\\.0056414493511584745\ \(0\)\
\-\ scheduled\\:\\ 0\\.0056270051208492135\ \(0\)\
\-\ order\\:\\ 0\\.0055985868376643684\ \(0\)\
\-\ 1\\.5\\:\\ 0\\.005584606067577116\ \(0\)\
\-\ chills\\:\\ 0\\.005584606067577116\ \(0\)\
\-\ characteristics\\:\\ 0\\.0055570852712400805\ \(0\)\
\-\ residual\\:\\ 0\\.0055435391443962295\ \(0\)\
\-\ metabolic\\:\\ 0\\.005516860880826024\ \(0\)\
\-\ hr\\:\\ 0\\.005439945194521536\ \(0\)\
\-\ 17\\:\\ 0\\.005439945194521536\ \(0\)\
\-\ denied\\:\\ 0\\.005439945194521536\ \(0\)\
\-\ heent\\:\\ 0\\.005403120518748076\ \(0\)\
\-\ 70\\:\\ 0\\.005367304866214594\ \(0\)\
\-\ vitals\\:\\ 0\\.005343961575495631\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.0053210278373898665\ \(0\)\
\-\ home\\:\\ 0\\.0053097101083139\ \(0\)\
\-\ shift\\:\\ 0\\.005298489528325153\ \(0\)\
\-\ b\\:\\ 0\\.00526539435448948\ \(0\)\
\-\ steroids\\:\\ 0\\.005254546246234976\ \(0\)\
\-\ 3\\:\\ 0\\.0052313085665530445\ \(0\)\
\-\ tumor\\:\\ 0\\.005208450461727611\ \(0\)\
\-\ ca\\:\\ 0\\.005201616362111137\ \(0\)\
\-\ t\\:\\ 0\\.005170857541967093\ \(0\)\
\-\ 26\\:\\ 0\\.005170857541967093\ \(0\)\
\-\ problems\\:\\ 0\\.005170857541967093\ \(0\)\
\-\ complaint\\:\\ 0\\.005160763364066556\ \(0\)\
\-\ woman\\:\\ 0\\.005160530581670343\ \(0\)\
\-\ restricted\\:\\ 0\\.005140805884157029\ \(0\)\
\-\ sensation\\:\\ 0\\.005130940255875483\ \(0\)\
\-\ discharged\\:\\ 0\\.00512114852812495\ \(0\)\
\-\ deficits\\:\\ 0\\.005111429601997475\ \(0\)\
\-\ regions\\:\\ 0\\.005111429601997475\ \(0\)\
\-\ basal\\:\\ 0\\.005092205879919442\ \(0\)\
\-\ were\\:\\ 0\\.00507264401748999\ \(0\)\
\-\ 16\\:\\ 0\\.005054586318416117\ \(0\)\
\-\ well\\:\\ 0\\.005053806412989937\ \(0\)\
\-\ gi\\:\\ 0\\.0050180191915632985\ \(0\)\
\-\ numerous\\:\\ 0\\.005009035035631584\ \(0\)\
\-\ report\\:\\ 0\\.0050001122054741986\ \(0\)\
\-\ diffusion\\:\\ 0\\.0050001122054741986\ \(0\)\
\-\ cbc\\:\\ 0\\.004991249869545598\ \(0\)\
\-\ clinic\\:\\ 0\\.004991249869545598\ \(0\)\
\-\ infarct\\:\\ 0\\.004956389415843427\ \(0\)\
\-\ tract\\:\\ 0\\.004947817650423611\ \(0\)\
\-\ admission\\:\\ 0\\.004922434531656158\ \(0\)\
\-\ smooth\\:\\ 0\\.004889339357820485\ \(0\)\
\-\ pathologic\\:\\ 0\\.004889339357820485\ \(0\)\
\-\ bp\\:\\ 0\\.004849114967406428\ \(0\)\
\-\ review\\:\\ 0\\.004841216517137196\ \(0\)\
\-\ neurological\\:\\ 0\\.004833365505293782\ \(0\)\
\-\ lateral\\:\\ 0\\.004827890315358302\ \(0\)\
\-\ resolution\\:\\ 0\\.004817803541233235\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.004802424663351422\ \(0\)\
\-\ measures\\:\\ 0\\.004779690359152901\ \(0\)\
\-\ rim\\:\\ 0\\.004728132539478003\ \(0\)\
\-\ multiple\\:\\ 0\\.00470537517249482\ \(0\)\
\-\ 40\\:\\ 0\\.004699558952794998\ \(0\)\
\-\ diameter\\:\\ 0\\.004699558952794998\ \(0\)\
\-\ motor\\:\\ 0\\.004664698499092826\ \(0\)\
\-\ 9\\:\\ 0\\.004617404830364065\ \(0\)\
\-\ 12\\:\\ 0\\.0045717626537546165\ \(0\)\
\-\ appear\\:\\ 0\\.0045717626537546165\ \(0\)\
\-\ infarction\\:\\ 0\\.00456537051611515\ \(0\)\
\-\ treatment\\:\\ 0\\.004521874404185325\ \(0\)\
\-\ placed\\:\\ 0\\.004521479933718282\ \(0\)\
\-\ 25\\:\\ 0\\.004515328442166108\ \(0\)\
\-\ includes\\:\\ 0\\.004503111628547497\ \(0\)\
\-\ vessels\\:\\ 0\\.004497045772918082\ \(0\)\
\-\ additional\\:\\ 0\\.0044790152864705845\ \(0\)\
\-\ extensive\\:\\ 0\\.0044671316633316934\ \(0\)\
\-\ persistent\\:\\ 0\\.004455355101315528\ \(0\)\
\-\ made\\:\\ 0\\.004449506368773148\ \(0\)\
\-\ vs\\:\\ 0\\.004398013033203657\ \(0\)\
\-\ midline\\:\\ 0\\.0043217386762595044\ \(0\)\
\-\ note\\:\\ 0\\.004311196767976196\ \(0\)\
\-\ skin\\:\\ 0\\.004290364621227422\ \(0\)\
\-\ 7\\:\\ 0\\.004280071737004016\ \(0\)\
\-\ within\\:\\ 0\\.004261781459832893\ \(0\)\
\-\ lungs\\:\\ 0\\.00422978901696768\ \(0\)\
\-\ incidental\\:\\ 0\\.00422978901696768\ \(0\)\
\-\ course\\:\\ 0\\.004215073782294956\ \(0\)\
\-\ confirmed\\:\\ 0\\.0042005223569762055\ \(0\)\
\-\ antibiotics\\:\\ 0\\.004195707657085622\ \(0\)\
\-\ has\\:\\ 0\\.004195294040507916\ \(0\)\
\-\ ventricle\\:\\ 0\\.004186131134089448\ \(0\)\
\-\ throughout\\:\\ 0\\.004181369053986832\ \(0\)\
\-\ compression\\:\\ 0\\.004181369053986832\ \(0\)\
\-\ metastasis\\:\\ 0\\.004181369053986832\ \(0\)\
\-\ pt\\:\\ 0\\.004153155234814055\ \(0\)\
\-\ breast\\:\\ 0\\.004120990776249087\ \(0\)\
\-\ laboratory\\:\\ 0\\.004116459785430152\ \(0\)\
\-\ mm\\:\\ 0\\.004107444649405235\ \(0\)\
\-\ abnormalities\\:\\ 0\\.00410296028980159\ \(0\)\
\-\ year\\-old\\:\\ 0\\.00410296028980159\ \(0\)\
\-\ wbc\\:\\ 0\\.004071993268726551\ \(0\)\
\-\ presence\\:\\ 0\\.004054621723473371\ \(0\)\
\-\ did\\:\\ 0\\.004033226981690096\ \(0\)\
\-\ identified\\:\\ 0\\.003991460184557282\ \(0\)\
\-\ hematoma\\:\\ 0\\.003975120102512535\ \(0\)\
\-\ effect\\:\\ 0\\.003954978108587248\ \(0\)\
\-\ kidney\\:\\ 0\\.003935141771307202\ \(0\)\
\-\ labs\\:\\ 0\\.0038849333423988733\ \(0\)\
\-\ heart\\:\\ 0\\.0038811498678546063\ \(0\)\
\-\ in\\:\\ 0\\.0038559223672964505\ \(0\)\
\-\ presentation\\:\\ 0\\.0038475825287465127\ \(0\)\
\-\ thickening\\:\\ 0\\.003786437346004381\ \(0\)\
\-\ fever\\:\\ 0\\.00377942827000257\ \(0\)\
\-\ and\\:\\ 0\\.003764894237536595\ \(0\)\
\-\ available\\:\\ 0\\.0037551882991369895\ \(0\)\
\-\ by\\:\\ 0\\.00371992393005196\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.0037179824629752097\ \(0\)\
\-\ \\>\\:\\ 0\\.003711330084534071\ \(0\)\
\-\ initial\\:\\ 0\\.00370141456637818\ \(0\)\
\-\ unremarkable\\:\\ 0\\.0036981260374928894\ \(0\)\
\-\ x\\:\\ 0\\.003685054033133957\ \(0\)\
\-\ central\\:\\ 0\\.0036753351070064823\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.0036340352829303812\ \(0\)\
\-\ differential\\:\\ 0\\.0035463527181084043\ \(0\)\
\-\ area\\:\\ 0\\.003531812083835643\ \(0\)\
\-\ aspect\\:\\ 0\\.0035088783457298788\ \(0\)\
\-\ of\\:\\ 0\\.0035027286514427896\ \(0\)\
\-\ be\\:\\ 0\\.0034451156165854354\ \(0\)\
\-\ clinical\\:\\ 0\\.0034370062745960835\ \(0\)\
\-\ days\\:\\ 0\\.003423626530943761\ \(0\)\
\-\ some\\:\\ 0\\.0033920630769500117\ \(0\)\
\-\ 6\\:\\ 0\\.0033361047861109466\ \(0\)\
\-\ decreased\\:\\ 0\\.003321250199639947\ \(0\)\
\-\ infection\\:\\ 0\\.0032470804889840614\ \(0\)\
\-\ lung\\:\\ 0\\.003235502117959145\ \(0\)\
\-\ not\\:\\ 0\\.0032282841091292426\ \(0\)\
\-\ y\\.o\\:\\ 0\\.0032240254020741176\ \(0\)\
\-\ lymphoma\\:\\ 0\\.003192416515541811\ \(0\)\
\-\ focal\\:\\ 0\\.0031901877178279765\ \(0\)\
\-\ weeks\\:\\ 0\\.0031702977214394094\ \(0\)\
\-\ t2\\:\\ 0\\.003161553946078891\ \(0\)\
\-\ all\\:\\ 0\\.0031593771103677003\ \(0\)\
\-\ time\\:\\ 0\\.0031550342839729573\ \(0\)\
\-\ she\\:\\ 0\\.0031356681587636237\ \(0\)\
\-\ scan\\:\\ 0\\.0031271522358601025\ \(0\)\
\-\ performed\\:\\ 0\\.0031144814787285213\ \(0\)\
\-\ 4\\:\\ 0\\.0031123815753974445\ \(0\)\
\-\ a\\:\\ 0\\.003110586680930206\ \(0\)\
\-\ trauma\\:\\ 0\\.003054913440206443\ \(0\)\
\-\ at\\:\\ 0\\.003026831772108844\ \(0\)\
\-\ lesions\\:\\ 0\\.0029902751716914346\ \(0\)\
\-\ prior\\:\\ 0\\.0028681212708527625\ \(0\)\
\-\ metastatic\\:\\ 0\\.002811907717145216\ \(0\)\
\-\ symptoms\\:\\ 0\\.002783865982873384\ \(0\)\
\-\ acute\\:\\ 0\\.0027580121949104513\ \(0\)\
\-\ physical\\:\\ 0\\.002740529764158481\ \(0\)\
\-\ surgery\\:\\ 0\\.0027124170775951304\ \(0\)\
\-\ chest\\:\\ 0\\.0026728483660882593\ \(0\)\
\-\ into\\:\\ 0\\.0026579429646532114\ \(0\)\
\-\ imaging\\:\\ 0\\.0026170899666086308\ \(0\)\
\-\ exam\\:\\ 0\\.002453900575097435\ \(0\)\
\-\ case\\:\\ 0\\.002443796644270942\ \(0\)\
\-\ demonstrates\\:\\ 0\\.002440027714579328\ \(0\)\
\-\ 2\\:\\ 0\\.0024053653549157466\ \(0\)\
\-\ \\-\\:\\ 0\\.0023944162858932855\ \(0\)\
\-\ findings\\:\\ 0\\.0023775646219476596\ \(0\)\
\-\ seen\\:\\ 0\\.002207356359565608\ \(0\)\
\-\ images\\:\\ 0\\.00214282861692726\ \(0\)\
\-\ which\\:\\ 0\\.002085156323192874\ \(0\)\
\-\ that\\:\\ 0\\.0019293865732795076\ \(0\)\
\-\ disease\\:\\ 0\\.0018258007074715085\ \(0\)\
\-\ to\\:\\ 0\\.001674776895854848\ \(0\)\
\-\ from\\:\\ 0\\.0016554715204630224\ \(0\)\
\-\ \\.\\:\\ 0\\.0015313525375325843\ \(0\)\
\-\ are\\:\\ 0\\.0015227109444831393\ \(0\)\
\-\ old\\:\\ 0\\.0011437053553754962\ \(0\)\
\-\ with\\:\\ 0\\.001070626447881344\ \(0\)\
